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Abstract 
Background: Fluid resuscitation is widely considered a life saving intervention in septic 
shock however recent evidence has questioned both its safety and efficacy in sepsis. 
This study sought to compare fluid resuscitation with vasopressors with vasopressors 
alone in a hyperdynamic model of ovine endotoxemia. 
 
Methods: Endotoxemic shock was induced in sixteen sheep after which they received 
fluid resuscitation with 40mls/kg of 0.9% saline or commenced haemodynamic support 
with protocolized noradrenaline and vasopressin. Microdialysis catheters were inserted 
into the arterial circulation, heart, brain, kidney and liver to monitor local metabolism. 
Blood samples were recovered to measure serum inflammatory cytokines, creatinine, 
troponin, ANP, BNP and hyaluronan. All animals were monitored and supported for 12 
hours after fluid resuscitation. 
 
Results: After resuscitation animals that received fluid resuscitation required 
significantly more noradrenaline to maintain the same mean arterial pressure in the 
subsequent 12 hours (68.9mg vs. 39.6mg p=0.04). Serum cytokines were similar 
between groups. Atrial natriuretic peptide increased significantly after fluid 
resuscitation compared to animals managed without fluid resuscitation (335ng/mL 
(256-382) vs. 233ng/mL (144 – 292) p 0.04). Cross-sectional time series analysis 
showed the rate of increase of the glycocalcyx glycosaminoglycan hyaluronan was 
greater in the fluid resuscitated group over the course of the study (p=0.02) 
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Conclusion: Fluid resuscitation resulted in a paradoxical increase in vasopressor 
requirement.  Additionally, It did not result in improvements in any of the measured 
microcirculatory or organ specific markers measured. The increase in vasopressor 
requirement seen may have been due to endothelial/glycocalyx damage secondary to 
ANP mediated glycocalyx shedding.  
 
 
Introduction 
Conservative estimates place the annual incidence of sepsis at 19 million cases with 
global estimates of costs upwards of 16 billion dollars (USD)1,2. Mortality remains high 
with estimates of greater than 20% in the developed world3.  
Fluid resuscitation (FR) is widely regarded as an essential life-saving intervention in 
sepsis with early FR recommended in all iterations of the international surviving sepsis 
guidelines4,5.  
The onset of sepsis is thought to result in pathological tissue hypoperfusion which if 
untreated leads to progressive organ dysfunction6. To this end FR is employed to 
increase cardiac output to reverse pathological hypoperfusion, preventing organ 
injury4,7. Whilst there has been widespread adoption there is emerging evidence that 
calls into question both the safety and efficacy of fluid resuscitation8-10. Importantly, 
prior to 2011 there were no randomised control trials (RCTs) directly examining the 
impact of fluid resuscitation on mortality in sepsis. 
 
The “Fluid Expansion as Supportive Therapy” (FEAST) trial was published in 2011 and 
remains the only RCT of fluid resuscitation in sepsis11. Children with severe sepsis were 
randomized to received FR with either 0.9% saline, 4% albumin or supportive care. The 
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trial demonstrated harm with FR with both resuscitation arms having a 45% relative 
increase in mortality11. Similarly, Andrews et al. conducted a RCT of early protocolized 
resuscitation with fluids and vasopressors in Zambian patients presenting with sepsis 
and found increased mortality in the resuscitated patients suggesting that there might 
be harm associate with the traditional resuscitation paradigm8. The results of these trial 
are in direct contrast to more than 50 years of medical theory and call into question the 
safety this common intervention and suggest it may in fact be harmful.   
 
In a secondary analysis of the FEAST trial authors demonstrated that the excess 
mortality in the FR arms was due to delayed cardiovascular collapse, a potentially novel 
mechanism of harm12. Consequently, we aimed to examine the effectiveness of FR in the 
treatment of septic shock in an animal model of endotoxemia. Our hypothesis was fluid 
resuscitation would not result in substantial improvements in endotoxemic shock and 
would lead to increased need for cardiovascular support after FR. The primary outcome 
of the study was vasopressor requirements in the post FR period. Additionally, as fluid 
resuscitation is used to maintain tissue perfusion we used tissue microdialysis of the 
vital organs to assess for pathological tissue hypoperfusion. Serum pro-inflammatory 
cytokines and biochemistry were measured throughout the study in to assess for a 
putative mechanistic connection between fluid resuscitation and the inflammatory state 
and the development of organ failure. Given the observation of delayed cardiovascular 
collapse in the FEAST study plasma atrial natriuretic peptide (ANP), brain natriuretic 
peptide (BNP), troponin and glycocalyx products were measured to assess for potential 
cardiac and endothelial damage. 
Limited haemodynamic and microdialysis data from the control group (NR) has been 
published previously13. 
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Materials and Methods 
 
This study was approved by the Animal Research and Ethics Committee of the 
Queensland University of Technology and The University of Queensland (Approval no. 
1400000032) and adhered to the Australian Code of Practice for the Care and Use of 
Animals for Scientific Purposes 8th Edition 2013 of the National Health and Medical 
Research Council (NHMRC)14.  
 
 
Animal preparation 
Sixteen Merino ewes (43.5 + 6.2kg) were fasted overnight for the study. Detailed 
description of animal care, data capture, anesthetic and surgical technique including 
placement of microdialysis catheters and microdialysis technique was in accordance 
with previously published methodology15. At the commencement of the study all 
animals were anesthetized with midazolam 0.5mg/kg (Pfizer (Perth) Bentley, WA, 
Australia), buprenorphine 300mcg (Reckitt Benckiser Healthcare, Hull, U.K.) and 
alfaxalone 3mg/kg (Jurox, Rutherford, NSW, Australia). Anesthesia was maintained with 
an infusion of alfaxalone 6 mg/kg/hr (Jurox, Rutherford, NSW, Australia), midazolam 
0.25 mg/kg/hr (Pfizer (Perth) Bentley, WA, Australia), fentanyl 15 mcg/kg/hr (Hameln 
Pharmaceuticals, Hameln, Germany) and ketamine 10 mg/kg/hr (Troy Laboratories, 
Glendenning NSW, Australia). All anesthetic and analgesic medications were titrated to 
maintain adequate surgical anesthesia.  
A central venous catheter (Arrow International, Reading, PA, USA), facial artery arterial 
catheter(Vygon arterial leadercath, Ecouen, France), pulmonary artery catheter(Swan-
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Ganz CCOmbo, Edwards Lifesciences, Irvine, CA, USA) were inserted to facilitate drug 
administration and cardiovascular monitoring.  
Microdialysis catheters (CMA 63 & 70 MD probes Kista, Sweden) were surgically 
inserted into the femoral artery, brain, heart, liver and left kidney. 
Throughout the study all animals received protocolized ventilation to maintain SaO2 
>94% and ETCO2 between 35-45mmHg. 
 
 
 
Experimental protocol 
After completion of surgical instrumentation, a 60 minute interval was allowed 
prior to commencement of the experimental protocol for physiological stabilization of 
the animal. 
To avoid profound pulmonary hypertension, the lipopolysaccharide infusion 
(LPS; E. coli serotype O55:B5) was commenced at 0.5 mcg/kg/hr  and escalated to 
4mcg/kg/hr over 4 hours(figure 1). Resuscitation occurred in the last hour of the 
endotoxin infusion. All animals had a mean arterial pressure (MAP) below 60mmHg 
prior to resuscitation. Animals received either fluid resuscitation with 40mls/kg of 
normal saline (Fluid resuscitation (FR) n=8) given over 1 hour or commenced 
vasopressor support (No fluid resuscitation(NR) n=8). After fluid resuscitation 
noradrenaline 60 mcg/ml in 5% dextrose (Hospira, Lake Forest, IL, USA) was 
commenced in order to maintain a MAP between 60-65 mmHg. In both groups the 
starting noradrenaline rate was 5mcg/min and it was titrated every 5 minutes to 
maintain the MAP in the target range. If the noradrenaline dose reached a pre-
determined 20 mcg/min, vasopressin (PPC, Richmond Hill, ON, Canada) was 
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commenced at 0.8 units/hr and increased to a maximum of 1.6 units/hr if hypotension 
persisted. Controlled administration of noradrenaline and vasopressin was achieved 
using a Gemini infusion pump (Alaris medical systems San Diego, CA, USA) and the 
administration protocol was the same for both groups. Animals were monitored for 12 
hours after the end of the endotoxin infusion and received a total of 13 hours of 
haemodynamic support (figure 1).  
 
 
 
Statistical analysis 
Data are presented as mean (SD) for normally distributed variables and median [IQR] 
for non-normally distributed variables. Only the mean arterial pressure, serum lactate, 
base excess and serum hyaluronan were normally distributed and values at each time 
point were compared with a two-sample T-test. All other variables were not normally 
distributed and values at individual time points were compared using the Wilcoxon 
rank-sum test. 
A p <0.05 was considered statistically significant. 
Repeated measures regression analysis was performed for hyaluronan, noradrenaline 
and vasopressin infusion rate over time to test for differences between groups. Fixed 
effect modeling was used throughout. Confirmation of the validity of this methodology 
was assessed using the Hausman test.  Independent variables used were resuscitation 
group (FR or NR) and time in hours and all models were tested for significant 
interactions between the independent predictors. Model diagnostics included testing 
the error terms (residuals) for normality using the Shapiro-Wilk test and 
homoscedasticity using the Breusch-Pagan test. Outliers and high leverage points were 
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identified using leverage to squared residual plots while influential points were 
identified using Cook’s distance method. 
Statistical analyses were performed using STATATM (StataCorp, TX, USA) statistical 
software package (version 13). One animal in the FR group was euthanized 90 minutes 
before the end of the experiment as it was deemed unsupportable by the investigators 
due to metabolic acidosis and refractory hypotension (pH <6.9 and MAP <60mmHg 
despite 240mcg/min of noradrenaline). 
 
 
 
Results 
 
Hemodynamic variables 
At baseline hemodynamic variables were similar in both groups. Endotoxemia produced 
a similar reduction in blood pressure in both groups with mean MAP between 44-
49mmHg prior to resuscitation (table 1 & figure 2A). Endotoxemia produced a 
temporary decrease in cardiac index (CI) one hour post-infusion that recovered to 
normal or supra-normal levels prior to resuscitation (table 1 figure 2B).  Fluid 
resuscitation produced a significant increase in cardiac index increasing from a median 
of 3.42 IQR (2.52-3.72) to 4.94 (3.91-5.62) (p=0.005). Systemic vascular resistance 
index (SVRI) was similar between groups at baseline and prior to resuscitation (figure 
2C). Fluid resuscitation resulted in a significant decrease in SVRI from 1110(950-1230) 
to 714(630-807) (p=0.02) associated with a relatively large increase in cardiac output 
and the concomitant modest increase in blood pressure.  
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Hemodynamic support 
Vasopressor use differed significantly between groups. Noradrenaline requirements 
rose for both groups throughout the monitoring period with a statistically significant 
difference between groups at both 8 and 12 hours of the monitoring period (figure 2D). 
The median noradrenaline rate 8 hours after resuscitation in the FR group was 
140mcg/min (96.5-172.5) and 62mcg/min (31.0-110.0) in the NR groups (p=0.03). At 
the end of the monitoring period the difference between groups had increased and was 
240.0mcg/min [104.0, 270.0] in the FR group compared to 73.0mcg/min [33.0, 137.5] 
in the NR group (p=0.02). Repeated measures regression analysis demonstrated that 
the rate of rise of was significantly greater for the FR compared to the NR group (Beta of 
18.74mcg/min/hr (p=0.001) vs. 6.51 mcg/min/hr (p=0.001) with the group time 
interaction term p<0.001) (figure 2D). With the exception of noradrenaline dose, no 
interactions were noted and the regression error terms were normally distributed and 
homoscedastic. All animals required full dose vasopressin (0.03units/min), though 
there was no significant difference in vasopressin use between groups (figure 2E). 
 
 
 
Biochemistry 
Serum lactate increased in both groups throughout the study however no statistically 
significant difference was observed at any point (figure 2F), though the  mean lactate 
did diverge over the course of the monitoring period with the final mean lactate in the 
FR arm being 11.22 (+7.65) and 5.07 (+2.02) in the NR resuscitation group (p=0.09). 
Serum base excess decreased in both groups throughout the study (figure 2G) and was 
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greater in the FR group compared to NR (p=0.048). This effect persisted throughout the 
study with the serum base excess being -12.52 (+2.82) in the FR group and -6.26(+4.94) 
at the end of the monitoring period (p=0.02). 
 
 
 
Microdialysis  
The lactate/pyruvate (L/P) ratios of both resuscitation strategies were similar across all 
organs (figure 3). For the arterial, brain, heart and kidney microdialysis samples there 
were no statistically significant differences between groups at any time points.  The 
liver microdialysis samples did demonstrate a statistically significant difference after 
resuscitation however the groups had large differences in baseline L/P ratios prior to 
resuscitation (figure 3E). None of the other timepoints in the liver microdialysis 
demonstrated significant differences.  
 
 
 
Inflammatory cytokines 
Endotoxemia produced large increases in all the measured serum cytokines (figure 4). 
TNF-alpha, IL-1Beta, IL-8 and IL-10 all exhibited a similar pattern of response with peak 
levels reached at or near the end of the endotoxin infusion before decreasing to near 
baseline values. IL-6 increased during endotoxemia and remained near maximal values 
throughout the monitoring period. The pattern of cytokine response between groups 
was remarkably similar with no significant differences at any of the time points for 
TNFα, IL-1β, IL-6 and IL-10. IL-8 values were similar between groups throughout the 
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experiment however final values at the end of the monitoring period were significantly 
different 1779pg/ml (759-5051) in the NR group compared to 5903pg/ml (3519-
14591) in the FR group (p=0.04) (figure 4). 
 
Cardiac, Endothelial and Renal Biomarkers 
Brain natriuretic peptide (BNP) rose during endotoxemia in both groups reaching 
maximum values at 3 hours. There were no significant differences in BNP values 
between groups at any time points (figure 5A). Endotoxemia resulted in a large increase 
in serum atrial natriuretic peptide (ANP) in both groups (Figure 5B). In the NR group, 
ANP peaked at a median of 297ng/ml (227-331) 3 hours into the endotoxin infusion 
then declined throughout the rest of the experimental period. In the FR group ANP 
reached a similar value after 3 hours 274ng/ml (142-418) however increased further 
after fluid resuscitation to 335ng/ml (256-382). There was a significant difference 
between median ANP between the two groups after resuscitation 335ng/mL (256-382) 
in the fluid resuscitation group vs. 233ng/mL (144 292) in the non-fluid resuscitated 
group (p=0.02). There was a large difference in high sensitivity serum troponin at the 
end of the study with median values of 8.60ng/ml (5.85-15.50) in the NF group 
compared to 52.5ng/ml (18-104) in the FR group (p=0.03) (figure 5E). 
 
The glycocalyx glycosaminoglycan (GAG) hyaluronan rose in both groups throughout 
the study (Figure 5C). Maximal mean values of 10734 (+8940) in the non-resuscitated 
group and 16681 (+13903) (p=0.33) were reached at the end of the experiment. The 
values between groups were not significantly different at any of the measured 
timepoints (figure 5C). Univariate time series cross-section analysis demonstrated that 
the rate of increase was significantly greater in the FR compared to the NR group 
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(p=0.02). Similarly multivariate regression analysis confirmed that FR was a predictor 
of an increased rate of rise of hyaluronan. 
 
Serum creatinine rose throughout the study in both groups reaching maximal median 
values of 263 µmol/L (191-335) in the FR group and 208 µmol/L (148-240) in the NR 
group (p=0.12) at the end of the study (figure 5D).  
 
 
Discussion 
Fluid resuscitation is promoted as a critical life saving intervention in sepsis and has 
been strongly recommended as the first line resuscitative therapy in all iterations of the 
international surviving sepsis guidelines4. It is thought that adequate fluid resuscitation 
in the early phase of sepsis improves shock and results in reduced vasopressor 
requirements later in a patients illness7. The key finding of this study was that fluid 
resuscitation given for endotoxemic shock produced short-lived haemodynamic 
improvements which were then followed by significantly increased vasopressors 
requirements in the subsequent 12 hours. These results challenge the current paradigm 
of resuscitation and warrant detailed discussion. 
 
Firstly, our study has a number of important differences to previous animal models 
demonstrating benefit of fluid resuscitation in sepsis and endotoxemia. Our model was 
developed to produce hyperdynamic/distributive shock with progressive decline in 
SVRI while maintaining near normal cardiac output at the initiation of resuscitation. 
These are the changes most often encountered in both human septic shock and 
endotoxemia16-19.  Previous studies that supported fluid resuscitation in animals have 
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used hypodynamic models of illness with rapid and severe reductions in cardiac output 
being the dominant cause of hypotension20-23. In a porcine model of endotoxemic shock, 
Oi et al. demonstrated improved mortality with fluid resuscitation with hypertonic 
saline-dextran. However after the administration of endotoxin untreated animals 
developed a profound and persistent low cardiac output state with a mortality of 77% 
at 5 hours (the end of the experiment). Similarly Bressack et al. were able to show 
improved outcomes with fluid resuscitation in a porcine model of septic shock, however 
animals in the study also developed severe cardiogenic shock. As hyperdynamic shock 
appears to be the most commonly seen presentation in human sepsis17-19, the rapid 
development of a life-threatening low cardiac output state in these models makes 
extrapolation of their findings to the clinical arena difficult. The incremental increase in 
rate of endotoxin infusion minimized the cardiac dysfunction which has hampered 
other models and  allowed our model to generate a hyperdynamic response similar to 
that seen in clinical sepsis. We believe therefore that this model better reflects the 
actual effect of fluid resuscitation in the clinical setting.  
Additionally, previous studies of fluid resuscitation have not had an alternative 
hemodynamic support strategy and have compared fluid resuscitation to untreated 
shock20-23. The relevance of such models is a concern as clinically fluid resuscitation is 
one element of a larger resuscitation strategy and short-term studies of it in isolation do 
not reflect how it is used clinically and may miss important interactions with other 
therapies. The advantage of this study is that it compares fluid resuscitation as part of a 
resuscitation strategy that is similar to current guideline recommendations with a 
viable alternative. This model better addresses the question of what is the likely impact 
of fluid resuscitation on current patients treated with septic shock and helps inform 
clinical studies of alternative strategies to management of septic shock. 
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As expected the fluid resuscitated animals had a large increase in cardiac output 
immediately after the fluid bolus was administered. While MAP improved over the hour 
of resuscitation, the magnitude of the increase was modest compared to the increase in 
cardiac output. This was due to a concurrent decrease in the SVRI of the resuscitated 
animals. This observation of fluid resuscitation induced vasodilation has been reported 
clinically in a number of studies. Monge Garcia et al described the immediate effects of 
fluid bolus resuscitation on arterial load in 81 septic patients24. 67% of the patients had 
an increase in cardiac output with fluid resuscitation, however this only resulted in an 
increase in MAP in 44% of those patients. Overall fluid resuscitation resulted in a 
decrease in SVRI that was most marked amongst patients that increased their cardiac 
output. In a similar observational study in 51 patients with sepsis Pierrakos et al found 
that for those that had a significant increase in their cardiac output fluid resuscitation 
resulted in a decrease in their SVRI25. The underlying mechanism of this vasodilation is 
unclear but it is thought due to occur due to a combination of baroreceptor mediated 
reduction in sympathetic tone and flow mediated vascular relaxation secondary to 
endothelial nitric oxide release24.  
 
The novel finding of this study was the divergent trends in vasopressor requirement 
after resuscitation. Interestingly, this was not apparent in the immediate post 
resuscitation period with noradrenaline requirements similar between groups for the 
first 3-4 hours. After 3-4 hours the noradrenaline requirement diverged, plateauing in 
the non-fluid resuscitated animals and increasing rapidly in the fluid resuscitated 
animals. This was reflected in a statistically significant difference in between the groups 
in the repeated measures linear regression analysis and differences between groups at 
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both 9 and 12 hours post resuscitation. This result has some parallels to the exploratory 
analysis of increased mortality seen in the landmark FEAST trial26. In the post hoc 
analysis of the excess mortality the authors noted that the largest contributor to the 
excess mortality seen with fluid resuscitation was delayed cardiovascular collapse 
occurring between 2-11 hours. This mode of death alone accounted for more than half 
of the additional deaths seen in the fluid resuscitated groups26. The results of our study 
support the hypothesis that fluid resuscitation produces delayed vascular injury that 
manifests as vascular hypo-reactiveness hours after the initial bolus is given. 
 
One might expect the above differences seen in the progression of shock to be 
attributable to alterations in inflammatory signalling and increased systemic 
inflammation due to fluid resuscitation.  However, the measured serum cytokines do 
not support this hypothesis. While endotoxemia produces large increases in all the 
measured cytokines, fluid resuscitation had little additional effect with both groups 
having very similar cytokine profiles over the entire course of the study. 
 
Recently the role of the endothelial glycocalyx in pathophysiology of sepsis has received 
increased attention. The glycocalyx being a thin gel structure lining the vascular 
endothelium thought to play a critical role in maintaining plasma oncotic pressure, 
prevention of leukocyte adhesion, inhibition of coagulation activation and vascular 
responsiveness27,28.  It has been demonstrated to be shed in both sepsis and 
endotoxemia with circulating levels of glycocalyx fragments being associated with 
mortality29,30. ANP has been shown to be a potent trigger for glycocalyx shedding in 
experimental models of exogenous ANP administration31,32. Similarly transgenic mice 
with knock-out inactivation of the endothelial guanylyl cylcase-A ANP receptor 
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demonstrated decreased vascular permeability compared to controls and did not have 
the same immediate increase in haematocrit from vascular leak in response to 
exogenous ANP33. Furthermore, hypervolemia has been shown to be a potent trigger for 
glycocalyx shedding potentially mediated by ANP release34. In our model, endotoxemia 
was associated with large increase in ANP (more than 14 fold in both groups). Fluid 
resuscitation resulted in a further rise in ANP whilst levels in the non-fluid resuscitated 
group had already begun to decline. This additional increase in ANP may be potentially 
pathological and cause increased glycocalyx shedding that may exacerbate vascular 
dysfunction. This is supported by the increased rate of rise of the glycosaminoglycan 
hyaluronan in the fluid resuscitated animals.  
 
One of the main aims of fluid resuscitation in sepsis is the reversal of pathologic tissue 
hypoperfusion preventing the onset of tissue ischemia and organ dysfunction6,7. We 
aimed to use tissue microdialysis to detect potentially favourable effects of fluid 
resuscitation on the microcirculation of the various vital organs. The lactate/pyruvate 
ratio is a sensitive marker of the redox state of a tissue with high levels associated with 
hypoperfusion and impaired oxidative metabolism35. It would be expected that if fluid 
resuscitation had reversed or improved pathological hypoperfusion this would be 
reflected in a comparatively lower L/P ratio in the respective organ. This was not 
demonstrated in arterial circulation, heart, brain or kidney with remarkably similar L/P 
ratios throughout the experimental period. The liver results are notable for the large 
difference in baseline values prior to resuscitation with the hepatic L/P ratio for the NR 
group nearly 3 fold higher than that of the FR group. There was a significant difference 
in the hepatic L/P ratios after resuscitation however the significance of this must be 
questioned given the large differences in baseline values. The authors are not able to 
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explain the discordant baseline values given the identical treatment of the experimental 
subjects prior to resuscitation. It is notable however that the hepatic L/P ratio in the NR 
decreased throughout the observation period and had approximated the FR group by 
the end of the study. 
 
Similarly if fluid resuscitation improved perfusion and prevented organ injury one 
might expect to see a difference in serum biomarkers over time between groups 
(creatinine and troponin). In this study there was no difference in serum creatinine 
between groups throughout the experiment with both groups developing evidence of 
acute kidney injury at a similar rate. Of note, serum troponin was similar between 
groups for the majority of the study however there was a dramatic late rise seen in the 
fluid resuscitated group. This finding is of interest as increases in serum troponin have 
been observed in septic patients without obstructive coronary disease and are 
associated with increased mortality36. The mechanism underlying this phenomena is 
unclear but a number of potential contributing mechanisms have been proposed 
including mitochondrial oxidative stress, microvascular thrombi and increased 
sarcolemma membrane permeability36,37.  Catecholamines have been shown to increase 
myocardial oxidative stress in experimental models,38 and in a murine model of sepsis 
Haileselassie et al demonstrated that increased oxidative stress was a central factor in 
development of septic induced myocardial dysfunction. The observed increase in 
troponin is a concerning find as it suggests the increased vasopressor requirement is 
not a benign epiphenomena and may produce secondary cardiac injury.  
 
Arterial lactate has been shown to be associated with increased mortality in sepsis39. 
Furthermore a serial decrease in arterial lactate during treatment is associated with 
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improved outcomes40. In this study, fluid resuscitation did not result in a significantly 
lower serum lactate in the immediate post resuscitation period or result in a 
significantly lower arterial lactate at any timepoint.  Contrary to what would be 
expected there was a trend towards higher arterial lactate in the FR group as the 
monitoring period progressed with the final median lactate in the FR group of 
9.1mmol/L compared to 4.9mmol/L in the NR group. Similarly the metabolic acidosis 
was worse in the FR sheep throughout the post-resuscitation period. Neither of these 
results support the conclusion that fluid resuscitation had favourable effects on the 
progression of metabolic derangements associated with endotoxemia. 
 
It is important to recognize the limitations of this study. The observed association 
between increased ANP, increased hyauronan and a need for increased vasopressors is 
interesting given the current understanding of the function of the glycocalyx in vascular 
function. However, this study is not able to quantify the degree to which the observed 
differences in both ANP and hyaluronan account the differences in vasopressor 
requirements. Future studies exploring this phenomena with either ANP inhibition or 
exogenous ANP are required to establish the degree to which changes in glycocalyx 
function are responsible for changes in vascular reactivity. Additionally, as the trial was 
investigating the harms seen in the FEAST study the same fluid bolus dose (40mls/kg) 
was used. This is more than is recommended by the surviving sepsis guidelines4 and the 
same effects may not be seen with different volumes or rates of administration. 
 
 
Conclusion 
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In conclusion, we found fluid resuscitation had a detrimental effect on endotoxemic 
shock with an increased vasopressor requirement in the 12 hours after resuscitation. 
This did not appear to be attributable to increased inflammatory signalling with the 
inflammatory cytokine results suggesting a non-infammatory mechanism for the 
difference seen. Fluid resuscitation was associated with an increase in plasma ANP and 
the glycocalyx glycosaminoglycan hyaluronan suggesting it resulted in iatrogenic 
damage to the glycocalyx. This may have been a causative factor in the need for higher 
doses of vasopressor after resuscitation. Additionally we were not able to demonstrate 
any beneficial effects of fluid resuscitation with respect to individual organ metabolism 
or any of the measured markers of injury or function.  
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Table 1: Systemic hemodynamic variables at baseline and throughout the experimental period 
in the fluid resuscitated (FR) and non-fluid resuscitated animals (NR) 
 
 Mean arterial pressure 
mmHg (mean and SD) 
Cardiac index 
L/min/m
2
 (median and IQR) 
Systemic vascular resistance index 
dynes · sec/cm
5 
(median and IQR) 
Timepoint FR group 
n=8 
NR group 
n=8  
P-value FR group 
n=8 
NR group 
n=8 
P-value FR  group n=8 NR group 
 n=8 
P-value 
T 0 (Baseline - Start 
endotoxin infusion) 
87.1 [78.7–
95.5] 
84.5 [69.2-
99.8] 
P = 0.68 2.78 [2.61, 
3.18] 
3.23 [2.78, 
3.74] 
P = 0.29 2270 [1918, 
2815] 
2000 [1757, 
2111] 
P = 0.21 
T 3 (Start resuscitation) 44.6 [35.2-
54] 
48.5 [38.8-
58.2] 
P = 0.43 3.42 [2.52, 
3.72] 
2.91 [2.70, 
3.04] 
P = 0.41 1110 [950, 
1230] 
1155 [1029, 
1340] 
P = 0.53 
T 4 (End 
resuscitation/endotoxin) 
52.8 [48.4-
57.2] 
60.4 [58.1-
62.7] 
P < 
0.001* 
4.94 [3.91, 
5.62] 
3.08 [2.94, 
3.70] 
P = 0.006* 714 [630, 
807] 
1434 [1146, 
1492] 
P < 
0.001* 
T 6 (2 hours after 
resuscitation) 
   3.52 [3.08, 
3.96] 
2.53 [2.27, 
3.28] 
P = 0.046* 1236 [1043, 
1379] 
1858 [1425, 
2176] 
P = 
0.02* 
T 8 (4 hours after 
resuscitation 
60.1 [57.5-
62.7] 
57.8 [53.6-
62] 
P = 0.20 3.62 [2.92, 
4.28] 
2.98 [2.59, 
3.66] 
P = 0.40 1212 [982, 
1372] 
1518 [1248, 
1722] 
P = 0.09 
T 12 (8 hours after 
resuscitation) 
   4.17 [3.62, 
4.98] 
3.10 [2.76, 
4.71] 
P = 0.21 1006 [871, 
1149] 
1412 [806, 
1513] 
P = 0.21 
T 16 (12 hours after 
resuscitation) 
56.9 [53.5-
60.3] 
61.9 [59.5-
64.3] 
P = 0.15 4.02 [3.14, 
5.26] 
3.85 [3.47, 
5.53] 
P = 0.99 910 [814, 
1036] 
1147 [827, 
1269] 
P = 0.25 
*Indicates statistically significant difference p value< 0.05. 
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 Figure 1: experimental timeline 
 
 
 
Schematic representation of the experimental protocol. Anesthesia and surgical instrumentation were followed by 
a 1 hour stabilization period during which no interventions were performed. Endotoxemic shock was induced with 
a 4 hour escalating dose endotoxin infusion. Resuscitation occurred in the last hour of the endotoxin infusion with 
animals either receiving a 40ml/kg bolus of 0.9% saline or commencing protocolized haemodynamic support. After 
resuscitation all animals were monitored for a further 12 hours during which both groups received protocolized 
haemodynamic and respiratory support. Blood gases were taken hourly during the 16 hours of the experiment and 
analyzed immediately on an ABL800 Flex (Radiometer, Copenhagen, Denmark). During the monitoring period 
hourly microdialysis samples were recovered and analyzed for lactate and pyruvate on an ISCUS clinical 
microdialysis analyzer (Hammarby Fabriksväg, Stockholm, Sweden). The bottom scale indicates the blood sampling 
timepoints throughout the experiment. * Indicates timepoints at which blood was taken for serum cytokines (IL-
1β, Il-6, IL-8, IL-10 and TNFα), troponin, ANP, BNP, hyaluronan and creatinine. ‡ Indicates timepoints at which 
blood was taken to measure hyaluronan only. ** Indicates timepoints at which blood was taken to measure serum 
cytokines and hyaluronan. ‡‡ Indicates timepoints blood was taken to measure serum cytokines. Cytokine 
measurements were performed using an in house ELISA for interleukin 1-beta (IL-1β), interleukin 6 (IL-6), 
interleukin 8 (IL-8), interleukin 10 (IL-10) and tumour necrosis factor alpha (TNFα). The methodology of the 
cytokine analysis has been published previously
15
. Cardiac troponin I was measured using Beckman Coulter Unicel 
DxI AccuTnI+3 immunoassay (Beckman Coulter, Brea, CA, USA). Hyaluronan was measured using a hyaluronan 
quantikine ELISA Kit (R&D systems, Minneapolis, USA). Serum ANP and BNP were measured using custom ovine 
radioimmunoassay (Endolab, Christchurch Heart Institute, Christchurch, New Zealand). Creatinine was measured 
using a COBAS Integra 400 blood chemistry analyzer (Roche Diagnostics, Australia). 
 
 
 
 
 
 
Page 25 of 29  AJRCCM Articles in Press. Published on 08-June-2018 as 10.1164/rccm.201801-0064OC 
 Copyright © 2018 by the American Thoracic Society 
Figure 2: Hemodynamic, vasopressors and acid/base variables during the experiment in both 
fluid resuscitated (FR) and non-fluid resuscitated animals (NR) 
 
 
 
 
(A) Mean arterial pressure during endotoxemia, resuscitation and post-resuscitation monitoring period. Grey 
shading corresponds to time period of endotoxin infusion. Results are expressed as mean + SD.  (B & C) Cardiac 
index and systemic vascular resistance during the experiment. Results are expressed as median values with IQR. 
(D) Noradrenaline infusion rate during the experiment, median and IQR. Linear regression analysis demonstrated 
the rate of increase to be significantly greater in the FR group. (E) Vasopressin infusion rates during the 
experiment, median and IQR. There was no significant difference in vasopressin infusion rates. All animals required 
the maximal dose of vasopressin by the end of the study. (F & G) Lactate and base excess over the experiment, 
data represented as mean + SD. * indicates timepoints with a statistically significant difference (p<0.05) 
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Figure 3: Individual organ lactate/pyruvate ratios recovered by microdialysis 
 
 
 
 
 
Individual organ lactate/pyruvate ratios for the period after resuscitation for fluid resuscitated (FR) and non-fluid 
resuscitated animals (NR). (A) Arterial L/P ratios during the post resuscitation period, values between groups were 
similar throughout. (B) Brain L/P ratios during the post resuscitation period, variance seen in IQR after hour 10 was 
due to the rapid increase in L/P ratio in a single animal in the final 3 hours of the experiment (>3400). (C) Kidney 
L/P ratio during the same period, there were no significant difference between groups at any of the timepoints. (D) 
Heart L/P ratio during the same period, there were no significant difference between groups at any of the 
timepoints. (E) Liver L/P ratios during the period after resuscitation. Values for the NR group started at a higher 
baseline than the FR group. After resuscitation values in the NR were significantly greater than those in the FR. All 
data represented as median values with IQR. * Indicates P<0.05. 
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 Figure 4: Plasma cytokines during the experiment in both fluid resuscitated (FR) and non-fluid 
resuscitated animals (NR) 
 
 
 
 
Plasma cytokine levels for both fluid resuscitated and non-fluid resuscitated animals throughout the experiment. 
(A) Serum TNF-α increased during endotoxemia reaching peak values in both groups at the beginning of 
resuscitation before returning to near baseline levels. (B) Serum IL-1β increased during endotoxemia in both 
groups reaching maximal values at the end of resuscitation. (C) Endotoxemia produced large increases in 
IL-6 in both groups that were sustained throughout the study. (D) Serum IL-8 reached maximal values in 
both groups at the beginning of resuscitation. IL-8 decreased in both groups after resuscitation, however 
there was a late increase in IL-8 in the FR animals with final IL-8 values statically significantly different 
between groups (p=0.04). (E) Endotoxin produced a large increase in IL-10 in both groups that slowly decreased 
throughout the monitoring period. Results are expressed as median values + IQR. 
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Figure 5: Cardiovascular and renal biomarkers during the experiment in both fluid 
resuscitated (FR) and non-fluid resuscitated animals (NR). 
 
 
 
 
(A) Endotoxemia produced a large increase in plasma BNP in both groups that then declined throughout the 
observation period in both groups (median + IQR). (B) Serum ANP rose in response to endotoxemia in both groups. 
Plasma ANP peaked at the initiation of resuscitation in the non-fluid resuscitation group. In the fluid resuscitation 
group plasma ANP rose with endotoxemia and increased further after resuscitation. There was a statistically 
significant difference in plasma ANP between groups after resuscitation (p=0.02) (median + IQR).  (C) Hyaluronan 
increased in both groups during the study(mean + s.d.). (D) Serum creatinine was not significantly different at any 
timepoint and increased in both groups throughout the study (median + IQR). (E) Serum troponin values were 
similar between groups until the end of the experiment where there was a large increase in the fluid resuscitated 
animals (median and IQR) (P=0.03).  
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